| Dr Jalpa K Patel, PHARMD | |
|
4175 E La Palma Ave, Suite 240, Anaheim, CA 92807-1842 | |
| (714) 279-6208 | |
| (714) 279-4689 |
| Full Name | Dr Jalpa K Patel |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 4175 E La Palma Ave, Anaheim, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174763189 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 62281 (California) | Primary |
| 183500000X | Pharmacist | 051292667 (Illinois) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jalpa K Patel, PHARMD 4175 E La Palma Ave, Suite 240, Anaheim, CA 92807-1842 Ph: (714) 279-6208 | Dr Jalpa K Patel, PHARMD 4175 E La Palma Ave, Suite 240, Anaheim, CA 92807-1842 Ph: (714) 279-6208 |
News Archive
Phthalates are widely used chemicals that recent studies suggest may have toxic effects on the developing endocrine and reproductive systems. A new study found evidence that infants may be absorbing these chemicals through commonly used baby products.
This substantially enhanced second-generation module of the FoodScreener™ for wine profiling allows easy and cost-efficient NMR-based wine analysis, now for the first time also for key regions in France, Italy and Spain. In addition to geographical origin, NMR Wine Profiling can determine further key authenticity parameters such as grape variety, vintage year and possible water addition. This comprehensive solution offers a quick, fully automated and cost-efficient tool to ensure wine quality and authenticity, protecting brand integrity and consumer confidence.
The U.S. Supreme Court's ruling this week in support of the Affordable Care Act was good news for the health insurance industry. If the court had ruled against the government, insurers were at risk of losing millions of customers.
HOI has one of the lowest if not the lowest surgical readmission rate in the State of California. Our all-cause readmission rate is 3.3% and our joint replacement readmission was at 1.8% based on published CMS reports we received in September 2013.
The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira (adalimumab) for multiple inflammatory diseases.
› Verified 9 days ago
Tarjani Lalitkumar Padmani, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 735 S Dove Tree Ln, Anaheim, CA 92808 Phone: 714-280-0825 | |
John Wang, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 88 E Orangethorpe Ave, Anaheim, CA 92801 Phone: 714-626-0014 | |
Mohamed Hussein, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1807 W Katella Ave Ste 206, Anaheim, CA 92804 Phone: 714-733-7978 Fax: 714-733-7969 | |
Kasey Kim, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1425 E Lincoln Ave Ste B, Anaheim, CA 92805 Phone: 714-776-1020 Fax: 714-776-7053 | |
Dr. Lan-phuong Nguyen, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 411 N Lakeview Ave, Kaiser Permanente Anticoagulation Service, Anaheim, CA 92807 Phone: 714-279-5403 Fax: 714-279-4809 | |
Hanny M Tadros, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 611 S Brookhurst St, Anaheim, CA 92804 Phone: 714-778-3123 | |
Atoussa Najafian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 440 N Euclid St, Anaheim, CA 92801 Phone: 714-491-1778 |